In NSCLC, CypA expression levels are significantly elevated compared to those observed in pulmonary sclerosing hemangioma (PSH), neuroendocrine carcinoma (NEC), and small cell lung carcinoma (SCLC) (Figure 1A). This evidence concerns the gene PPIA and lung sclerosing hemangioma.